Display options
Cite
Lener T, Gimona M, Aigner L, et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015;4:30087doi: 10.3402/jev.v4.30087.
Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F. A., Del Portillo, H. A., O'Driscoll, L., Fais, S., Falcon-Perez, J. M., Felderhoff-Mueser, U., Fraile, L., Gho, Y. S., Görgens, A., Gupta, R. C., Hendrix, A., Hermann, D. M., Hill, A. F., Hochberg, F., Horn, P. A., de Kleijn, D., Kordelas, L., Kramer, B. W., Krämer-Albers, E. M., Laner-Plamberger, S., Laitinen, S., Leonardi, T., Lorenowicz, M. J., Lim, S. K., Lötvall, J., Maguire, C. A., Marcilla, A., Nazarenko, I., Ochiya, T., Patel, T., Pedersen, S., Pocsfalvi, G., Pluchino, S., Quesenberry, P., Reischl, I. G., Rivera, F. J., Sanzenbacher, R., Schallmoser, K., Slaper-Cortenbach, I., Strunk, D., Tonn, T., Vader, P., van Balkom, B. W., Wauben, M., Andaloussi, S. E., Théry, C., Rohde, E., & Giebel, B. (2015). Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. Journal of extracellular vesicles, 430087. https://doi.org/10.3402/jev.v4.30087
Lener, Thomas, et al. "Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper." Journal of extracellular vesicles vol. 4 (2015): 30087. doi: https://doi.org/10.3402/jev.v4.30087
Lener T, Gimona M, Aigner L, Börger V, Buzas E, Camussi G, Chaput N, Chatterjee D, Court FA, Del Portillo HA, O'Driscoll L, Fais S, Falcon-Perez JM, Felderhoff-Mueser U, Fraile L, Gho YS, Görgens A, Gupta RC, Hendrix A, Hermann DM, Hill AF, Hochberg F, Horn PA, de Kleijn D, Kordelas L, Kramer BW, Krämer-Albers EM, Laner-Plamberger S, Laitinen S, Leonardi T, Lorenowicz MJ, Lim SK, Lötvall J, Maguire CA, Marcilla A, Nazarenko I, Ochiya T, Patel T, Pedersen S, Pocsfalvi G, Pluchino S, Quesenberry P, Reischl IG, Rivera FJ, Sanzenbacher R, Schallmoser K, Slaper-Cortenbach I, Strunk D, Tonn T, Vader P, van Balkom BW, Wauben M, Andaloussi SE, Théry C, Rohde E, Giebel B. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015 Dec 31;4:30087. doi: 10.3402/jev.v4.30087. eCollection 2015. PMID: 26725829; PMCID: PMC4698466.
Copy Download .nbib Format: NLM
Share it on

J Extracell Vesicles. 2015 Dec 31;4:30087. doi: 10.3402/jev.v4.30087. eCollection 2015.

Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.

Journal of extracellular vesicles

Thomas Lener, Mario Gimona, Ludwig Aigner, Verena Börger, Edit Buzas, Giovanni Camussi, Nathalie Chaput, Devasis Chatterjee, Felipe A Court, Hernando A Del Portillo, Lorraine O'Driscoll, Stefano Fais, Juan M Falcon-Perez, Ursula Felderhoff-Mueser, Lorenzo Fraile, Yong Song Gho, André Görgens, Ramesh C Gupta, An Hendrix, Dirk M Hermann, Andrew F Hill, Fred Hochberg, Peter A Horn, Dominique de Kleijn, Lambros Kordelas, Boris W Kramer, Eva-Maria Krämer-Albers, Sandra Laner-Plamberger, Saara Laitinen, Tommaso Leonardi, Magdalena J Lorenowicz, Sai Kiang Lim, Jan Lötvall, Casey A Maguire, Antonio Marcilla, Irina Nazarenko, Takahiro Ochiya, Tushar Patel, Shona Pedersen, Gabriella Pocsfalvi, Stefano Pluchino, Peter Quesenberry, Ilona G Reischl, Francisco J Rivera, Ralf Sanzenbacher, Katharina Schallmoser, Ineke Slaper-Cortenbach, Dirk Strunk, Torsten Tonn, Pieter Vader, Bas W M van Balkom, Marca Wauben, Samir El Andaloussi, Clotilde Théry, Eva Rohde, Bernd Giebel

Affiliations

  1. Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.
  2. Department of Blood Group Serology and Transfusion Medicine, University Hospital, Salzburger Landeskliniken GesmbH (SALK), Salzburg, Austria.
  3. Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  4. Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.
  5. Molecular Biotechnology Center, Department of Medical Sciences, University of Turin, Turin, Italy.
  6. Laboratory of Immunomonitoring in Oncology, UMS 3655 CNRS/US23 Inserm, Villejuif, France.
  7. Centre of Clinical Investigation in Biotherapy CICBT 1248, Institut Gustave Roussy, Villejuif, France.
  8. Division of Hematology & Oncology, Rhode Island Hospital, Providence, RI, USA.
  9. The Alpert Medical School of Brown University, Providence, RI, USA.
  10. Department of Physiology, Faculty of Biology, Pontificia-Universidad Católica de Chile, Santiago, Chile.
  11. ICREA at Barcelona Centre for International Health Research (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
  12. Institut d'Investigació Germans Trias i Pujol (IGTP), Badalona, Spain.
  13. School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland;
  14. Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.
  15. Anti-Tumor Drugs Section, Department of Therapeutic Research and Medicines Evaluation, National Institute of Health (ISS), Rome, Italy.
  16. Metabolomics Unit, CIC bioGUNE, CIBERehd, Bizkaia Technology Park, Derio, Spain.
  17. IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
  18. Department of Paediatrics I, Neonatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  19. Departament de Producció Animal, ETSEA, Universitat de Lleida, Lleida, Spain.
  20. Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea.
  21. Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA.
  22. James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
  23. Laboratory of Experimental Cancer Research, Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium.
  24. Department of Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  25. Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia.
  26. Massachusetts General Hospital, Boston, MA, USA.
  27. Department of Surgery, YLL School of Medicine, NUS, Singapore, Singapore.
  28. Department of Bone Marrow Transplantation, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  29. Experimental Perinatology/Neonatology, School of Mental Health and Neuroscience, School of Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
  30. Molecular Cell Biology and Focus Program Translational Neurosciences, University of Mainz, Mainz, Germany.
  31. Research and Cell Services, Finnish Red Cross Blood Service, Helsinki, Finland.
  32. Division of Stem Cell Neurobiology, Department of Clinical Neurosciences, Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, UK.
  33. European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
  34. Department of Cell Biology, Center for Molecular Medicine, University Medical Center, Utrecht, The Netherlands.
  35. Institute of Medical Biology, Agency for Science Technology and Research (A*STAR), Singapore, Singapore.
  36. Krefting Research Centre, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  37. Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  38. Dpto. Biología Celular y Parasitologia, Facultat de Farmacia, Universitat de Valencia, Valencia, Spain.
  39. Joint Research Unit on Endocrinology, Nutrition and Clinical Dietetics, Universitat de València-Health Research Institute La Fe, Valencia, Spain.
  40. Institute for Environmental Health Sciences and Hospital Infection Control Medical Center, University of Freiburg, Freiburg im Breisgau, Germany.
  41. Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan.
  42. Departments of Transplantation and Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
  43. Centre for Cardiovascular Research, Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg University, Aalborg, Denmark.
  44. Mass Spectrometry and Proteomics, Institute of Biosciences and BioResources, National Research Council of Italy, Naples, Italy.
  45. BASG - Bundesamt für Sicherheit im Gesundheitswesen - Federal Office for Safety in Health Care, AGES - Agentur für Gesundheit und Ernährungssicherheit - Austrian Agency for Health and Food Safety, Institut Überwachung - Institute Surveillance, Wien, Austria.
  46. Institute of Molecular Regenerative Medicine, Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria;
  47. Ralf Sanzenbacher, Paul-Ehrlich-Institut, Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
  48. Cell Therapy Facility, Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.
  49. Experimental & Clinical Cell Therapy Institute, Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, Salzburg, Austria.
  50. Institute for Transfusion Medicine Dresden, German Red Cross Blood Donation Service North-East, Dresden, Germany.
  51. Laboratory of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
  52. Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
  53. Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
  54. Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
  55. Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  56. INSERM U932, Institut Curie, Paris, France.
  57. Department of Blood Group Serology and Transfusion Medicine, University Hospital, Salzburger Landeskliniken GesmbH (SALK), Salzburg, Austria; [email protected].
  58. Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; [email protected].

PMID: 26725829 PMCID: PMC4698466 DOI: 10.3402/jev.v4.30087

Abstract

Extracellular vesicles (EVs), such as exosomes and microvesicles, are released by different cell types and participate in physiological and pathophysiological processes. EVs mediate intercellular communication as cell-derived extracellular signalling organelles that transmit specific information from their cell of origin to their target cells. As a result of these properties, EVs of defined cell types may serve as novel tools for various therapeutic approaches, including (a) anti-tumour therapy, (b) pathogen vaccination, (c) immune-modulatory and regenerative therapies and (d) drug delivery. The translation of EVs into clinical therapies requires the categorization of EV-based therapeutics in compliance with existing regulatory frameworks. As the classification defines subsequent requirements for manufacturing, quality control and clinical investigation, it is of major importance to define whether EVs are considered the active drug components or primarily serve as drug delivery vehicles. For an effective and particularly safe translation of EV-based therapies into clinical practice, a high level of cooperation between researchers, clinicians and competent authorities is essential. In this position statement, basic and clinical scientists, as members of the International Society for Extracellular Vesicles (ISEV) and of the European Cooperation in Science and Technology (COST) program of the European Union, namely European Network on Microvesicles and Exosomes in Health and Disease (ME-HaD), summarize recent developments and the current knowledge of EV-based therapies. Aspects of safety and regulatory requirements that must be considered for pharmaceutical manufacturing and clinical application are highlighted. Production and quality control processes are discussed. Strategies to promote the therapeutic application of EVs in future clinical studies are addressed.

Keywords: haematology; immunology; neurobiology; regulation; stem cells; tissue regeneration; tumour vaccination

References

  1. Science. 1999 Apr 2;284(5411):143-7 - PubMed
  2. Vaccine. 1999 May 14;17(19):2336-45 - PubMed
  3. Cancer Res. 1999 Dec 1;59(23):5875-7 - PubMed
  4. Br J Haematol. 2000 Apr;109(1):235-42 - PubMed
  5. Nat Med. 2001 Mar;7(3):297-303 - PubMed
  6. Tissue Eng. 2001 Apr;7(2):211-28 - PubMed
  7. Haematologica. 2001 Oct;86(10):1099-100 - PubMed
  8. Blood. 2002 May 15;99(10):3838-43 - PubMed
  9. Nat Rev Neurosci. 2002 May;3(5):401-9 - PubMed
  10. Nature. 2002 Jul 4;418(6893):41-9 - PubMed
  11. Lancet. 2002 Jul 27;360(9329):295-305 - PubMed
  12. J Immunol Methods. 2002 Dec 15;270(2):211-26 - PubMed
  13. N Engl J Med. 2003 Feb 13;348(7):593-600 - PubMed
  14. Nature. 2003 Apr 17;422(6933):688-94 - PubMed
  15. Exp Hematol. 2003 Oct;31(10):890-6 - PubMed
  16. Circ Res. 2003 Nov 28;93(11):1023-5 - PubMed
  17. Gut. 2003 Dec;52(12):1690-7 - PubMed
  18. Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):288-93 - PubMed
  19. Cytometry A. 2004 Feb;57(2):94-9 - PubMed
  20. J Immunol. 2004 Feb 15;172(4):2137-46 - PubMed
  21. Blood. 2004 Jun 15;103(12):4619-21 - PubMed
  22. Lancet. 2004 May 1;363(9419):1439-41 - PubMed
  23. Infect Immun. 2004 Jul;72(7):4127-37 - PubMed
  24. Blood. 2004 Nov 1;104(9):2752-60 - PubMed
  25. J Exp Med. 2004 Jul 19;200(2):123-35 - PubMed
  26. J Transl Med. 2005 Feb 21;3(1):9 - PubMed
  27. J Transl Med. 2005 Mar 02;3(1):10 - PubMed
  28. Vaccine. 2005 Mar 18;23(17-18):2374-8 - PubMed
  29. Blood. 2005 Jul 1;106(1):216-23 - PubMed
  30. Nat Med. 2005 Apr;11(4):367-8 - PubMed
  31. Blood. 2005 Sep 1;106(5):1525-31 - PubMed
  32. Nature. 2005 Jul 14;436(7048):266-71 - PubMed
  33. Blood. 2006 Jan 1;107(1):367-72 - PubMed
  34. Stem Cells. 2006 Feb;24(2):357-67 - PubMed
  35. Circulation. 2005 Sep 13;112(11):1618-27 - PubMed
  36. Blood. 2006 May 1;107(9):3546-54 - PubMed
  37. Leukemia. 2006 May;20(5):847-56 - PubMed
  38. Vaccine. 2006 Mar 24;24(14):2643-55 - PubMed
  39. Future Oncol. 2005 Dec;1(6):779-86 - PubMed
  40. FASEB J. 2006 Apr;20(6):661-9 - PubMed
  41. Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13174-9 - PubMed
  42. Cancer Immunol Immunother. 2007 May;56(5):641-8 - PubMed
  43. Blood. 2007 Mar 1;109(5):1801-9 - PubMed
  44. Stem Cells. 2007 Jul;25(7):1746-52 - PubMed
  45. Nat Cell Biol. 2007 Jun;9(6):654-9 - PubMed
  46. J Exp Med. 2007 Jun 11;204(6):1257-65 - PubMed
  47. Blood. 2007 Oct 1;110(7):2440-8 - PubMed
  48. Clin Microbiol Rev. 2007 Jul;20(3):489-510, table of contents - PubMed
  49. Regen Med. 2007 Jul;2(4):417-23 - PubMed
  50. Blood. 2007 Nov 1;110(9):3234-44 - PubMed
  51. J Leukoc Biol. 2007 Nov;82(5):1070-82 - PubMed
  52. Microbes Infect. 2007 Nov-Dec;9(14-15):1614-22 - PubMed
  53. Stem Cells. 2008 Jan;26(1):212-22 - PubMed
  54. J Immunol. 2007 Dec 1;179(11):7692-701 - PubMed
  55. Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22 - PubMed
  56. Exp Hematol. 2008 Mar;36(3):309-18 - PubMed
  57. Cancer Res. 2008 Feb 15;68(4):1228-35 - PubMed
  58. Traffic. 2008 Jun;9(6):871-81 - PubMed
  59. Mol Ther. 2008 Apr;16(4):782-90 - PubMed
  60. Cell Stem Cell. 2008 Apr 10;2(4):313-9 - PubMed
  61. Purinergic Signal. 2007 Mar;3(1-2):171-80 - PubMed
  62. Nat Cell Biol. 2008 May;10(5):619-24 - PubMed
  63. Lancet. 2008 May 10;371(9624):1579-86 - PubMed
  64. J Immunol. 2008 Jun 15;180(12):8146-52 - PubMed
  65. J Proteome Res. 2008 Aug;7(8):3475-80 - PubMed
  66. J Immunol. 2008 Sep 15;181(6):3933-46 - PubMed
  67. Nat Cell Biol. 2008 Dec;10(12):1470-6 - PubMed
  68. J Immunol. 2009 Feb 1;182(3):1548-59 - PubMed
  69. Vaccine. 2009 Mar 10;27(11):1750-7 - PubMed
  70. J Gene Med. 2009 Apr;11(4):313-25 - PubMed
  71. Blood. 2009 Jun 25;113(26):6716-25 - PubMed
  72. Stem Cell Res. 2007 Nov;1(2):129-37 - PubMed
  73. J Am Soc Nephrol. 2009 May;20(5):1053-67 - PubMed
  74. Vaccine. 2009 Jun 24;27 Suppl 2:B3-12 - PubMed
  75. PLoS One. 2009 Jun 19;4(6):e5959 - PubMed
  76. Cell Stem Cell. 2009 Jul 2;5(1):54-63 - PubMed
  77. Brain. 2009 Aug;132(Pt 8):2239-51 - PubMed
  78. J Cell Mol Med. 2010 Jun;14(6B):1605-18 - PubMed
  79. Lab Invest. 2009 Nov;89(11):1317-28 - PubMed
  80. Ann N Y Acad Sci. 2009 Sep;1176:124-34 - PubMed
  81. Ann Neurol. 2009 Sep;66(3):343-54 - PubMed
  82. J Biol Chem. 2009 Dec 4;284(49):34211-22 - PubMed
  83. Stem Cells Dev. 2010 May;19(5):693-706 - PubMed
  84. Stem Cell Res. 2010 May;4(3):214-22 - PubMed
  85. Infect Immun. 2010 Apr;78(4):1601-9 - PubMed
  86. Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6328-33 - PubMed
  87. J Biol Chem. 2010 Jun 4;285(23):17442-52 - PubMed
  88. Blood. 2010 Sep 30;116(13):2385-94 - PubMed
  89. Mol Ther. 2010 Sep;18(9):1606-14 - PubMed
  90. Stem Cells. 2010 Aug;28(8):1446-55 - PubMed
  91. Exp Cell Res. 2010 Oct 1;316(16):2609-17 - PubMed
  92. Mol Cell. 2010 Jul 9;39(1):133-44 - PubMed
  93. J Neurosci. 2010 Jul 14;30(28):9603-11 - PubMed
  94. Proteomics. 2010 Sep;10(17):3190-202 - PubMed
  95. J Cell Mol Med. 2010 Sep;14(9):2190-9 - PubMed
  96. Annu Rev Microbiol. 2010;64:163-84 - PubMed
  97. J Immunother. 2011 Jan;34(1):65-75 - PubMed
  98. PLoS One. 2010 Dec 17;5(12):e15353 - PubMed
  99. Nephrol Dial Transplant. 2011 May;26(5):1474-83 - PubMed
  100. Nat Biotechnol. 2011 Apr;29(4):341-5 - PubMed
  101. Cell Prolif. 2011 Apr;44 Suppl 1:1-8 - PubMed
  102. J Transl Med. 2011 Apr 25;9:47 - PubMed
  103. Nanomedicine. 2011 Dec;7(6):780-8 - PubMed
  104. Colloids Surf B Biointerfaces. 2011 Oct 1;87(1):146-50 - PubMed
  105. Arthritis Rheum. 2011 Sep;63(9):2547-57 - PubMed
  106. Cancer Res. 2011 Aug 1;71(15):5235-44 - PubMed
  107. J Immunol. 2011 Jul 15;187(2):676-83 - PubMed
  108. Vaccine. 2011 Aug 5;29(34):5705-10 - PubMed
  109. Circ Res. 2011 Sep 16;109(7):724-8 - PubMed
  110. Clin Vaccine Immunol. 2011 Nov;18(11):1803-8 - PubMed
  111. Mol Ther. 2011 Oct;19(10):1769-79 - PubMed
  112. J Virol. 2011 Dec;85(24):12844-54 - PubMed
  113. Vaccine. 2011 Nov 21;29(50):9361-7 - PubMed
  114. PLoS One. 2011;6(10):e25294 - PubMed
  115. Nanomedicine. 2012 Jul;8(5):712-20 - PubMed
  116. Blood. 2012 Jan 19;119(3):756-66 - PubMed
  117. PLoS One. 2011;6(10):e26588 - PubMed
  118. Cancer Lett. 2012 Feb 1;315(1):28-37 - PubMed
  119. Future Microbiol. 2011 Nov;6(11):1371-81 - PubMed
  120. Brain. 2012 Feb;135(Pt 2):447-60 - PubMed
  121. Nephrology (Carlton). 2012 Jul;17(5):493-500 - PubMed
  122. Pediatr Res. 2012 Apr;71(4 Pt 2):445-51 - PubMed
  123. PLoS One. 2012;7(3):e33115 - PubMed
  124. Cell Transplant. 2013;22(5):871-9 - PubMed
  125. Kidney Int. 2012 Aug;82(4):412-27 - PubMed
  126. Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):75-85 - PubMed
  127. Nat Rev Immunol. 2012 Apr 25;12(5):383-96 - PubMed
  128. Curr Pharm Des. 2012;18(21):3086-100 - PubMed
  129. Stem Cells. 2012 Jun;30(6):1297-310 - PubMed
  130. Nucleic Acids Res. 2012 Sep 1;40(17):e130 - PubMed
  131. Cell Stem Cell. 2012 Jun 14;10(6):709-716 - PubMed
  132. Front Physiol. 2012 Jun 13;3:205 - PubMed
  133. Klin Padiatr. 2012 Jul;224(4):233-40 - PubMed
  134. Pharmacol Rev. 2012 Jul;64(3):676-705 - PubMed
  135. J Immunol. 2012 Jul 15;189(2):777-85 - PubMed
  136. Stem Cells Dev. 2012 Dec 10;21(18):3289-97 - PubMed
  137. Leukemia. 2013 Feb;27(2):500-3 - PubMed
  138. Blood Transfus. 2012 May;10 Suppl 2:s25-38 - PubMed
  139. J Cardiovasc Pharmacol Ther. 2013 Jan;18(1):78-86 - PubMed
  140. J Immunol. 2012 Sep 15;189(6):2833-42 - PubMed
  141. PLoS One. 2012;7(9):e44092 - PubMed
  142. Stem Cells Dev. 2013 Mar 15;22(6):845-54 - PubMed
  143. Cytometry A. 2013 Jan;83(1):48-61 - PubMed
  144. PLoS One. 2012;7(9):e45974 - PubMed
  145. Mol Ther. 2013 Jan;21(1):185-91 - PubMed
  146. Circulation. 2012 Nov 27;126(22):2601-11 - PubMed
  147. Cytometry A. 2013 Feb;83(2):242-50 - PubMed
  148. Nat Protoc. 2012 Dec;7(12):2112-26 - PubMed
  149. N Engl J Med. 2012 Dec 13;367(24):2322-33 - PubMed
  150. Nat Commun. 2012;3:1282 - PubMed
  151. Vox Sang. 2013 Jan;104(1):67-91 - PubMed
  152. Cell. 2012 Dec 21;151(7):1542-56 - PubMed
  153. PLoS Biol. 2012;10(12):e1001450 - PubMed
  154. Biol Res. 2012;45(3):257-68 - PubMed
  155. Stem Cells Transl Med. 2012 Dec;1(12):898-908 - PubMed
  156. Stem Cells Transl Med. 2012 Dec;1(12):909-20 - PubMed
  157. Nat Med. 2013 Jan;19(1):35-42 - PubMed
  158. Stem Cell Res Ther. 2013 Jan 28;4(1):11 - PubMed
  159. Sci Rep. 2013;3:1197 - PubMed
  160. Proteomics. 2013 May;13(10-11):1660-6 - PubMed
  161. J Immunol. 2013 Mar 15;190(6):2712-9 - PubMed
  162. Cancer Lett. 2013 Jul 10;335(1):201-4 - PubMed
  163. J Cell Biol. 2013 Feb 18;200(4):373-83 - PubMed
  164. J Tissue Eng Regen Med. 2015 Nov;9(11):E84-97 - PubMed
  165. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD003311 - PubMed
  166. J Clin Invest. 2013 Apr;123(4):1542-55 - PubMed
  167. J Immunol. 2013 Apr 15;190(8):4092-102 - PubMed
  168. Hum Gene Ther. 2013 May;24(5):533-44 - PubMed
  169. Blood. 2013 May 9;121(19):3997-4006, S1-15 - PubMed
  170. BioDrugs. 2013 Jun;27(3):263-74 - PubMed
  171. Nat Rev Drug Discov. 2013 May;12(5):347-57 - PubMed
  172. Stem Cell Res Ther. 2013 Apr 25;4(2):34 - PubMed
  173. Vet Parasitol. 2013 Aug 1;195(3-4):272-85 - PubMed
  174. Stem Cells. 2013 Dec;31(12):2737-46 - PubMed
  175. Glia. 2013 Sep;61(9):1379-401 - PubMed
  176. Cancer Res. 2013 Jul 1;73(13):3865-76 - PubMed
  177. Nat Commun. 2013;4:1867 - PubMed
  178. Eur J Immunol. 2013 Sep;43(9):2430-40 - PubMed
  179. Mol Ther. 2013 Jul;21(7):1345-57 - PubMed
  180. PLoS One. 2013 Jul 08;8(7):e68451 - PubMed
  181. PLoS Biol. 2013 Jul;11(7):e1001604 - PubMed
  182. Biochem Biophys Res Commun. 2013 Aug 16;438(1):152-5 - PubMed
  183. Blood. 2013 Sep 12;122(11):1863-72 - PubMed
  184. Pharmaceuticals (Basel). 2013;6(5):659-80 - PubMed
  185. Stem Cells. 2014 Jan;32(1):116-25 - PubMed
  186. Eur J Immunol. 2013 Dec;43(12):3279-90 - PubMed
  187. J Cereb Blood Flow Metab. 2013 Nov;33(11):1711-5 - PubMed
  188. Am J Pathol. 2013 Oct;183(4):1183-1196 - PubMed
  189. PLoS One. 2013 Aug 22;8(8):e72604 - PubMed
  190. PLoS One. 2013 Aug 26;8(8):e73031 - PubMed
  191. J Control Release. 2013 Nov 28;172(1):229-238 - PubMed
  192. J Neurooncol. 2013 Dec;115(3):343-51 - PubMed
  193. ACS Nano. 2013 Sep 24;7(9):7698-710 - PubMed
  194. J Extracell Vesicles. 2013 Feb 15;2:null - PubMed
  195. J Extracell Vesicles. 2013 May 27;2:null - PubMed
  196. Vaccine. 2013 Oct 25;31(45):5262-8 - PubMed
  197. Glia. 2013 Nov;61(11):1795-806 - PubMed
  198. PLoS One. 2013 Sep 18;8(9):e75227 - PubMed
  199. Cell Immunol. 2013 Sep-Oct;285(1-2):62-8 - PubMed
  200. Proteomics. 2013 Nov;13(22):3354-64 - PubMed
  201. Nat Mater. 2013 Nov;12(11):967-77 - PubMed
  202. Cell Rep. 2013 Nov 27;5(4):986-96 - PubMed
  203. Blood. 2014 Jan 30;123(5):687-96 - PubMed
  204. J Mol Med (Berl). 2014 Apr;92(4):387-97 - PubMed
  205. Biomaterials. 2014 Feb;35(7):2383-90 - PubMed
  206. J Extracell Vesicles. 2013 Dec 10;2:null - PubMed
  207. Nat Commun. 2013;4:2980 - PubMed
  208. Stem Cells Dev. 2014 Jun 1;23(11):1233-44 - PubMed
  209. J Extracell Vesicles. 2013 Dec 23;2:null - PubMed
  210. Leukemia. 2014 Apr;28(4):970-3 - PubMed
  211. Ther Deliv. 2014 Feb;5(2):105-7 - PubMed
  212. PLoS One. 2014 Feb 06;9(2):e88193 - PubMed
  213. Nanomedicine (Lond). 2014 Feb;9(2):177-80 - PubMed
  214. PLoS One. 2014 Feb 18;9(2):e88685 - PubMed
  215. Nat Biotechnol. 2014 Mar;32(3):252-60 - PubMed
  216. Biomaterials. 2014 May;35(14):4390-400 - PubMed
  217. Stem Cell Res Ther. 2014 Mar 19;5(2):40 - PubMed
  218. J Trauma Acute Care Surg. 2014 Apr;76(4):991-7 - PubMed
  219. Biochim Biophys Acta. 2014 Aug;1846(1):75-87 - PubMed
  220. Clin Exp Immunol. 2014 Aug;177(2):531-43 - PubMed
  221. Semin Cancer Biol. 2014 Oct;28:51-7 - PubMed
  222. J Proteomics. 2014 Jun 25;106:46-60 - PubMed
  223. Nature. 2014 May 15;509(7500):310-7 - PubMed
  224. Semin Cancer Biol. 2014 Oct;28:58-67 - PubMed
  225. PLoS Biol. 2014 Jun 03;12(6):e1001874 - PubMed
  226. Stem Cell Res Ther. 2014 Jun 10;5(3):76 - PubMed
  227. Exp Neurol. 2014 Nov;261:53-64 - PubMed
  228. Stem Cells. 2015 Jul;33(7):2158-68 - PubMed
  229. Sci Signal. 2014 Jul 01;7(332):ra63 - PubMed
  230. Immunity. 2014 Jul 17;41(1):89-103 - PubMed
  231. PLoS One. 2014 Jul 31;9(7):e103811 - PubMed
  232. J Control Release. 2014 Oct 28;192:262-70 - PubMed
  233. Anal Bioanal Chem. 2014 Dec;406(30):7855-66 - PubMed
  234. Arthritis Res Ther. 2014 Aug 04;16(4):R163 - PubMed
  235. J Control Release. 2014 Dec 10;195:72-85 - PubMed
  236. Mov Disord. 2014 Oct;29(12):1476-85 - PubMed
  237. Philos Trans R Soc Lond B Biol Sci. 2014 Sep 26;369(1652):null - PubMed
  238. Front Immunol. 2014 Aug 11;5:382 - PubMed
  239. J Extracell Vesicles. 2014 Aug 27;3:null - PubMed
  240. Mol Cell. 2014 Oct 23;56(2):193-204 - PubMed
  241. Cell Rep. 2014 Sep 25;8(6):1649-1658 - PubMed
  242. J Extracell Vesicles. 2014 Sep 30;3:null - PubMed
  243. Bioinformatics. 2015 Mar 15;31(6):933-9 - PubMed
  244. J Extracell Vesicles. 2014 Nov 06;3:25011 - PubMed
  245. Nat Commun. 2014 Nov 25;5:5488 - PubMed
  246. Brain Res. 2015 Jan 12;1594:293-304 - PubMed
  247. J Extracell Vesicles. 2014 Dec 10;3:25922 - PubMed
  248. Nano Lett. 2015 Jan 14;15(1):266-74 - PubMed
  249. PLoS One. 2014 Dec 16;9(12):e115316 - PubMed
  250. Virol J. 2014 Dec 19;11:225 - PubMed
  251. J Control Release. 2015 Feb 10;199:145-55 - PubMed
  252. Stem Cells. 2015 Apr;33(4):1200-12 - PubMed
  253. J Extracell Vesicles. 2014 Dec 22;3:25040 - PubMed
  254. J Extracell Vesicles. 2014 Dec 22;3:25465 - PubMed
  255. J Extracell Vesicles. 2014 Dec 22;3:26913 - PubMed
  256. J Control Release. 2015 Feb 28;200:87-96 - PubMed
  257. Front Chem. 2014 Dec 23;2:113 - PubMed
  258. Nanomedicine. 2015 May;11(4):879-83 - PubMed
  259. Semin Cell Dev Biol. 2015 Apr;40:97-104 - PubMed
  260. Mass Spectrom Rev. 2016 Jan-Feb;35(1):3-21 - PubMed
  261. Stem Cells. 2015 Jun;33(6):1878-91 - PubMed
  262. J Extracell Vesicles. 2015 Mar 26;4:26373 - PubMed
  263. PLoS One. 2015 Mar 30;10(3):e0121123 - PubMed
  264. Stem Cells Transl Med. 2015 May;4(5):513-22 - PubMed
  265. Leukemia. 2015 Sep;29(9):1839-46 - PubMed
  266. Blood. 2015 May 14;125(20):3202-12 - PubMed
  267. FEBS Lett. 2015 May 8;589(11):1257-65 - PubMed
  268. J Extracell Vesicles. 2015 Apr 20;4:26316 - PubMed
  269. J Am Soc Nephrol. 2015 Oct;26(10):2349-60 - PubMed
  270. J Extracell Vesicles. 2015 May 14;4:27066 - PubMed
  271. Int J Cardiol. 2015 Aug 1;192:61-9 - PubMed
  272. Cell. 2015 May 21;161(5):1046-1057 - PubMed
  273. Stem Cells. 2015 Sep;33(9):2798-810 - PubMed
  274. J Extracell Vesicles. 2015 May 27;4:26883 - PubMed
  275. Stem Cells. 2015 Sep;33(9):2748-61 - PubMed
  276. J Intern Med. 2015 Sep;278(3):251-63 - PubMed
  277. Hum Gene Ther. 2015 Aug;26(8):506-17 - PubMed
  278. Science. 2015 Sep 11;349(6253):1232-6 - PubMed
  279. Stem Cell Res Ther. 2015 Apr 10;6:10 - PubMed
  280. J Nutr. 2015 Oct;145(10):2201-6 - PubMed
  281. Anal Chem. 2015 Sep 15;87(18):9225-33 - PubMed
  282. Stem Cells Transl Med. 2015 Oct;4(10):1131-43 - PubMed
  283. Stem Cell Res Ther. 2015 Nov 11;6:212 - PubMed
  284. Cancer Lett. 2016 Feb 1;371(1):48-61 - PubMed
  285. Sci Rep. 2015 Dec 03;5:17622 - PubMed
  286. Oncoimmunology. 2015 Aug 12;5(4):e1071008 - PubMed
  287. Stem Cells Transl Med. 2016 Jun;5(6):754-63 - PubMed
  288. Br J Clin Pharmacol. 2018 Jul;84(7):1401-1409 - PubMed
  289. J Cell Biol. 1985 Sep;101(3):942-8 - PubMed
  290. J Histochem Cytochem. 1979 Jan;27(1):350-2 - PubMed
  291. Br J Haematol. 1971 Jul;21(1):53-69 - PubMed
  292. Exp Hematol. 1974;2(2):83-92 - PubMed
  293. Transplantation. 1968 Mar;6(2):230-47 - PubMed
  294. J Cell Biol. 1969 Apr;41(1):59-72 - PubMed
  295. Cell. 1983 Jul;33(3):967-78 - PubMed
  296. J Cell Biol. 1983 Aug;97(2):329-39 - PubMed
  297. J Exp Med. 1996 Mar 1;183(3):1161-72 - PubMed
  298. Science. 1997 Feb 14;275(5302):964-7 - PubMed
  299. Infect Immun. 1998 Apr;66(4):1334-41 - PubMed
  300. Nat Med. 1998 May;4(5):594-600 - PubMed
  301. Infect Immun. 1999 Jan;67(1):113-9 - PubMed

Publication Types

Grant support